Clinical Trial Update: Quality Improvement PrecivityAD Clinician Survey (QUIP I)

View source ↗

Summary

This completed clinical trial update reports the QUIP I clinician survey evaluating the PrecivityAD test sponsored by C2N Diagnostics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Decline
• Cognitive Impairment
• Dementia

Snippet

Sponsor: C2N Diagnostics | Conditions: Alzheimer Disease, Mild Cognitive Impairment | Status: COMPLETED